MRI and Clinical Features of Nonenhancing <i>IDH</i> -Wild-Type Glioblastomas: How to Make an Early Diagnosis and Distinguish from Mimics

BACKGROUND AND PURPOSE: -wt GBMs to help radiologists in differentiating them from nonmalignant mimic diagnoses (eg, encephalitis). Additionally, the histologic, genomic, and survival profiles of nonenhancing GBMs were compared with those of enhancing GBMs. MATERIALS AND METHODS: -wt GBMs with nonmalignant mimics. Histopathologic and genomic analyses were performed on institutional cases. Overall survival between nonenhancing and enhancing GBMs was compared using Kaplan-Meier analysis. RESULTS: = .078). CONCLUSIONS: Nonenhancing GBMs demonstrate distinct MRI features that must be recognized for early diagnosis and differentiation from nonmalignant mimics. Nonenhancing GBMs demonstrated longer overall survival compared with enhancing GBMs, though they were not statistically significant.

Authors

Institutions

Publication Details

Journal
American Journal of Neuroradiology
Published
2026-05-01
DOI
https://doi.org/10.3174/ajnr.a9272
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MRI and Clinical Features of Nonenhancing IDH -Wild-Type Glioblastomas: How to Make an Early Diagnosis and Distinguish from Mimics

James Ryan Loftus, Sonal Patel, Daniel Orringer, Rajan Jain et al.
American Journal of Neuroradiology
Glioma Diagnosis and Treatment
article

MRI and Clinical Features of Nonenhancing IDH -Wild-Type Glioblastomas: How to Make an Early Diagnosis and Distinguish from Mimics

James Ryan Loftus, Sonal Patel, Daniel Orringer, Rajan Jain, Matija Snuderl, Kanwar P. Singh, Matthew D. Lee
article en

Abstract

BACKGROUND AND PURPOSE: -wt GBMs to help radiologists in differentiating them from nonmalignant mimic diagnoses (eg, encephalitis). Additionally, the histologic, genomic, and survival profiles of nonenhancing GBMs were compared with those of enhancing GBMs. MATERIALS AND METHODS: -wt GBMs with nonmalignant mimics. Histopathologic and genomic analyses were performed on institutional cases. Overall survival between nonenhancing and enhancing GBMs was compared using Kaplan-Meier analysis. RESULTS: = .078). CONCLUSIONS: Nonenhancing GBMs demonstrate distinct MRI features that must be recognized for early diagnosis and differentiation from nonmalignant mimics. Nonenhancing GBMs demonstrated longer overall survival compared with enhancing GBMs, though they were not statistically significant.

American Journal of NeuroradiologyVol. 47(5)
University of Virginia Medical Center (US), New York University (US)
Openalex Percentile: Top 7%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.